Defining the diagnosis of invasive aspergillosis

References

• Kontoyiannis DP, Bodey GP. Invasive aspergillosis in 2002: an update. Eur J Clin Microbiol Infect Dis 2002; 21: 161–172
   PubMed Web of Science ®Google Scholar
• Marr KA, Carter RA, Crippa F, et al. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909–17
   PubMed Web of Science ®Google Scholar
• Marr KA, Carter RA, Boeckh M, et al. Invasive aspergillosis in allogeneic transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100: 4358–4366
   PubMed Web of Science ®Google Scholar
• Steinbach WJ, Benjamin DK, Kontoyiannis DP, et al. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis 2004; 39: 192–198
   PubMed Web of Science ®Google Scholar
• Balajee SA, Weaver M, Imhof A, et al. Aspergillus fumigatus variant with decreased susceptibility to multiple antifungals. Antimicrob Agents Chemother 2004; 48: 1197–1203
   PubMed Web of Science ®Google Scholar
• Pavie J, Lacroix C, Hermoso DG, et al. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis. J Clin Microbiol 2005; 43: 4902–4904
   PubMed Web of Science ®Google Scholar
• Nucci M, Marr KA. Emerging fungal diseases. Clin Infect Dis 2005; 41: 521–526
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP, Lionakis MS, Lewis RE, et al. Zygomycosis in the era of Aspergillus-active antifungal therapy in a tertiary care cancer center: a case-control observational study of 27 recent cases. J Infect Dis 2005; 191: 1350–1360
   PubMed Web of Science ®Google Scholar
• Gerson SL, Talbot GH, Lusk E, et al. Invasive pulmonary aspergillosis in adult acute leukemia: clinical clues to its diagnosis. J Clin Oncol 1985; 3: 1109–1116
   PubMed Web of Science ®Google Scholar
• Chamilos, G, Kontoyiannis, DP. Pulmonary aspergillosis, zygomycosis and candidiasis. In:. AP Fishman, (ed.), Fishman's Pulmonary Diseases and Disorders. 4th edn., New York: McGraw-Hill, in press.
   Google Scholar
• Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7–14
   PubMed Web of Science ®Google Scholar
• Subira M, Martino R, Rovira M, et al. Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Ann Hematol 2003; 82: 80–82
   PubMed Web of Science ®Google Scholar
• Chamilos, G, Luna, M, Lewis, RE, , et al. Invasive fungal infections in patients with hematological malignancies (1989–2003): an autopsy study. In: 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, 16–19 December, 2005: Abstract #M-1720, Washington DC: ASM Press.
   Google Scholar
• Horvath JA, Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 1996; 100: 171–178
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP, Sumoza D, Tarrand JJ, et al. Significance of aspergillemia in patients with cancer: a 10-year study. Clin Infect Dis 2000; 31: 188–189
   PubMed Web of Science ®Google Scholar
• Tarrand JJ, Han XY, Kontoyiannis DP, et al. Aspergillus hyphae in infected tissue: evidence of physiologic adaptation and effect on culture recovery. J Clin Microbiol 2005; 43: 382–386
   PubMed Web of Science ®Google Scholar
• Hayden RT, Isolato PA, Parrett T, et al. In situ hybridization for the differentiation of Aspergillus, Fusarium, and Pseudallescheria species in tissue section. Diagn Mol Pathol 2003; 12: 21–26
   PubMed Web of Science ®Google Scholar
• Caillot D, Casasnovas O, Bernard A, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997; 15: 139–47
   PubMed Web of Science ®Google Scholar
• Caillot D, Couaillier JF, Casasnovas O, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001; 19: 253–259
   PubMed Web of Science ®Google Scholar
• Greene, RE, Schlamm, HT, Stark, P, , et al. Impact of halo and air-crescent signs on initial identification of invasive pulmonary aspergillosis: prevalence, variability of diagnosis and utility. 13th European Congress of Clinical Microbiology and Infectious Diseases, GlasgowUK, 13 May 2003: Oral Presentation O397.
   Google Scholar
• Lee YR, Choi YW, Lee KJ, et al. CT halo sign: the spectrum of pulmonary diseases. Br J Radiol 2005; 78: 862–865
   PubMed Web of Science ®Google Scholar
• Young RC, Bennett JE. Invasive aspergillosis. Absence of detectable antibody response. Am Rev Respir Dis 1971; 104: 710–716
   PubMed Web of Science ®Google Scholar
• Tomee JF, Mannes GP, van der Bij W, et al. Serodiagnosis and monitoring of Aspergillus infections after lung transplantation. Ann Intern Med 1996; 125: 197–201
   PubMed Web of Science ®Google Scholar
• Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis. 2005; 5: 609–622
   PubMed Web of Science ®Google Scholar
• Mennink-Kersten MA, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004; 4: 349–357
   PubMed Web of Science ®Google Scholar
• Maertens J, Van Eldere J, Verhaegen J, et al. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002; 186: 1297–1306
   PubMed Web of Science ®Google Scholar
• Weisser M, Rausch C, Droll A, et al. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies. Clin Infect Dis 2005; 41: 1143–1149
   PubMed Web of Science ®Google Scholar
• Verweij PE, Weemaes CM, Curfs JH, et al. Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis. J Clin Microbiol 2000; 38: 3900–3901
   PubMed Web of Science ®Google Scholar
• Marr KA, Balajee SA, McLaughlin L, et al. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis. 2004; 190: 641–649
   PubMed Web of Science ®Google Scholar
• Marr KA, Leisenring W. Design issues in studies evaluating diagnostic tests for aspergillosis. Clin Infect Dis 2005; 41: S381–S386
   PubMed Web of Science ®Google Scholar
• Klont RR, Mennink-Kersten MA, Verweij PE. Utility of Aspergillus antigen detection in specimens other than serum specimens. Clin Infect Dis 2004; 39: 1467–1474
   PubMed Web of Science ®Google Scholar
• Obayashi T, Yoshida M, Mori T, et al. Plasma (1– > 3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995; 345: 17–20
   PubMed Web of Science ®Google Scholar
• Odabasi Z, Mattiuzzi G, Estey G, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39: 199–205
   PubMed Web of Science ®Google Scholar
• Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1– > 3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41: 654–659
   PubMed Web of Science ®Google Scholar
• Kawazu M, Kanda Y, Nannya Y, et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1–3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 2004; 42: 2733–2741
   PubMed Web of Science ®Google Scholar
• Pazos C, Ponton J, Del Palacio A. Contribution of (1– > 3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 2005; 43: 299–305
   PubMed Web of Science ®Google Scholar
• Mennink-Kersten, MA, Ruegebrink, D, Warris, A, , et al. Detection of circulating glucan in patients receiveing intravenous amoxicillin-clavulananic acid. Second Advances Against Aspergillosis. 22–25 February, AthensGreece. P064.
   Google Scholar
• Chen SC, Halliday CL, Meyer W. Review of nucleic acid-based diagnostic tests for systemic mycoses with an emphasis on polymerase chain reaction-based assays. Med Mycol 2002; 40: 333–357
   PubMed Web of Science ®Google Scholar
• Bretagne S, Costa JM. Towards a molecular diagnosis of invasive aspergillosis and disseminated candidosis. FEMS Immunol Med Microbiol 2005; 45: 361–368
   PubMedGoogle Scholar
• Mennink-Kersten MA, Ruegebrink D, Wasei N, et al. In vitro release by Aspergillus fumigatus of galactofuran antigens,1,3-β-D-Glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis. J Clin Microbiol 2006; 44: 1711–1718
   PubMed Web of Science ®Google Scholar
• Einsele H, Quabeck K, Muller K-D, et al. Prediction of invasive pulmonary aspergillosis from colonisation of lower respiratory tract before marrow transplantation. Lancet 1998; 352: 1443
   PubMed Web of Science ®Google Scholar
• Buchheidt D, Baust C, Skladny H, et al. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. Clin Infect Dis 2001; 33: 428–435
   PubMed Web of Science ®Google Scholar
• Becker MJ, de Marie S, Willemse D, et al. Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model. J Clin Microbiol 2000; 38: 1434–1438
   PubMed Web of Science ®Google Scholar
• Bretagne S, Costa JM, Bart-Delabesse E, et al. Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis. Clin Infect Dis 1998; 26: 1407–1412
   PubMed Web of Science ®Google Scholar
• Kami M, Tanaka Y, Kanda Y, et al. Computed tomographic scan of the chest, latex agglutination test and plasma (1AE3)-beta-D-glucan assay in early diagnosis of invasive pulmonary aspergillosis: a prospective study of 215 patients. Haematologica 2000; 85: 745–752
   PubMed Web of Science ®Google Scholar
• Scotter JM, Chambers ST. Comparison of galactomannan detection, PCR-enzyme-linked immunosorbent assay, and real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model and effect of caspofungin acetate. Clin Diagn Lab Immunol 2005; 12: 1322–1327
   PubMedGoogle Scholar
• Scotter JM, Campbell P, Anderson TP, et al. Comparison of PCR-ELISA and galactomannan detection for the diagnosis of invasive aspergillosis. Pathology 2005; 37: 246–253
   PubMed Web of Science ®Google Scholar
• Buchheidt D, Hummel M, Schleiermacher D, et al. Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients. Br J Hematol 2004; 125: 196–202
   PubMed Web of Science ®Google Scholar
• Florent M, Katsahian S, Vekhoff A, et al. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies. J Infect Dis 2006; 193: 741–747
   PubMed Web of Science ®Google Scholar
• Whiting P, Rutjes AW, Reitsma JB, et al. Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med 2004; 140: 189–202
   PubMed Web of Science ®Google Scholar
• Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310–350
   PubMed Web of Science ®Google Scholar
• Lewis RE, Wiederhold NP, Chi J, et al. Detection of gliotoxin in experimental and human aspergillosis. Infect Immun 2005; 73: 635–637
   PubMed Web of Science ®Google Scholar
• Lewis RE, Wiederhold NP, Lionakis SM, et al. Frequency and species distribution of gliotoxin-producing Aspergillus isolates recovered from patients at a tertiary-care cancer center. J Clin Microbiol 2005; 43: 6120–6122
   PubMed Web of Science ®Google Scholar
• Scotter, J, Chambers, ST, Syhre, M. Direct detection of A. fumigatus from breath samples. 43rd Annual Meeting of Infectious Diseases Society of America, 6–9, October, 2005, San Francisco, CA, A# 278.
   Google Scholar
• Sarfati, J, Monod, M, Recco, P, , et al. Do recombinant antigens have a future as diagnostic markers for invasive aspergillosis?. Second Advances Against Aspergillosis. 22–25, February, AthensGreece. P059.
   Google Scholar
• Lionakis MS, Lahdenranta J, Sun J, et al. Development of a ligand-directed approach to study the pathogenesis of invasive aspergillosis. Infect Immun 2005; 73: 7747–7758
   PubMed Web of Science ®Google Scholar
• Sonnet S, Buitrago-Tellez CH, Tamm M, et al. Direct detection of angioinvasive pulmonary aspergillosis in immunosuppressed patients: preliminary results with high-resolution 16-MDCT angiography. Am J Roentgenol 2005; 184: 746–751
   PubMed Web of Science ®Google Scholar
• Bleeker-Rovers CP, Warris A, Drenth JP, et al. Diagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography. Clin Microbiol Infect 2005; 11: 493–495
   PubMed Web of Science ®Google Scholar
• Ho AY, Pagliuca A, Maisey MN, et al. Positron emission scanning with 18-FDG in the diagnosis of deep fungal infections. Br J Haematol 1998; 101: 392–393
   PubMed Web of Science ®Google Scholar
• Maertens J, Theunissen K, Verhoef G, et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high-risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005; 41: 1242–1250
   PubMed Web of Science ®Google Scholar